The ticagrelor market is estimated to be valued at US$ 1,617.6 million in 2023 and is expected to exhibit a CAGR of 12.3% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Ticagrelor is an oral, reversible antagonist of the platelet P2Y12 adenosine diphosphate (ADP) receptor. It is used alongside aspirin to prevent ... Read more
